Biofilm Associated Persistence and Drug Tolerance in Mycobacteria Within Host Microenvironments

Area of Science:

• Microbiology
• Infectious Diseases
• Drug Discovery

Background:

• Mycobacterial biofilms, particularly those of Mycobacterium tuberculosis (Mtb), are highly organized structures.
• These biofilms are embedded in an extracellular matrix, restricting antibiotic penetration and shielding bacteria from immune responses.
• Biofilm-associated drug tolerance contributes to chronic tuberculosis, treatment failure, and relapse.

Purpose of the Study:

• To provide an integrated overview of mycobacteria within biofilm microenvironments.
• To emphasize mechanisms underlying biofilm-associated drug tolerance.
• To discuss therapeutic strategies for overcoming biofilm-induced drug tolerance.

Main Methods:

• Review of experimental and clinical evidence on mycobacterial biofilms in TB lesions.
• Analysis of biological and physiological states within biofilms.
• Critical discussion of therapeutic strategies, including synergistic antibiotic combinations and peptide-antibiotic therapies.

Main Results:

• Biofilms create heterogeneous microenvironments favoring non-replicating cells, reducing antimicrobial efficacy.
• Evidence links biofilm-like communities in TB lesions to disease chronicity and treatment failure.
• Specific therapeutic approaches show promise in disrupting biofilms and enhancing drug efficacy.

Conclusions:

• Mycobacterial biofilms are a key factor in tuberculosis treatment challenges.
• Understanding biofilm-associated drug tolerance is essential for developing new therapies.
• Targeting biofilm architecture and enhancing drug penetration are promising strategies to combat drug-tolerant tuberculosis.